What are the options for pain management in Herpes Zoster (shingles)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pain management in shingles should follow guidelines for neuropathic pain, as trigeminal post-herpetic neuralgia has the same clinical features as other neuralgias. When considering the management of shingles, it's crucial to prioritize a multi-faceted approach that combines medications and supportive care to minimize morbidity, mortality, and improve quality of life.

Key Considerations

  • For acute shingles pain, medications such as acetaminophen or NSAIDs like ibuprofen can be initiated, but the focus should be on neuropathic pain guidelines as suggested by the study on differential diagnosis of facial pain and guidelines for management 1.
  • Anticonvulsants, tricyclic antidepressants, and topical treatments can provide relief by modulating different pain pathways.
  • Antiviral medications should be started within 72 hours of rash onset to reduce pain severity and duration.

Treatment Approach

  • Start with acetaminophen (500-1000mg every 6 hours) or NSAIDs like ibuprofen (400-600mg every 6-8 hours) for mild pain.
  • For moderate to severe pain, consider prescription medications like gabapentin or pregabalin, which are effective in managing neuropathic pain, as indicated by the approach to managing trigeminal post-herpetic neuralgia 1.
  • Topical treatments such as lidocaine patches or capsaicin cream can provide additional relief.
  • Antiviral medications like acyclovir, valacyclovir, or famciclovir should be initiated promptly to reduce viral replication and limit nerve damage.

Supportive Care

  • Cool compresses, loose clothing, and adequate rest support recovery and pain management.
  • Calamine lotion can soothe skin irritation, contributing to overall comfort and quality of life.

From the FDA Drug Label

In a double-blind, placebo-controlled study of immunocompetent patients with localized cutaneous zoster infection, acyclovir (800 mg 5 times daily for 10 days) shortened the times to lesion scabbing, healing, and complete cessation of pain, and reduced the duration of viral shedding and the duration of new lesion formation In a similar double-blind, placebo-controlled study, acyclovir (800 mg 5 times daily for 7 days) shortened the times to complete lesion scabbing, healing, and cessation of pain; reduced the duration of new lesion formation; and reduced the prevalence of localized zoster-associated neurologic symptoms (paresthesia, dysesthesia, or hyperesthesia) Acyclovir can be used for pain management in shingles by reducing the duration of pain and new lesion formation, as well as shortening the times to complete cessation of pain 2.

  • Key benefits of acyclovir in shingles include:
    • Reduced duration of pain
    • Shortened time to complete cessation of pain
    • Reduced duration of new lesion formation
    • Reduced prevalence of localized zoster-associated neurologic symptoms Treatment with acyclovir is most effective if started within the first 48 hours of rash onset, and adults greater than 50 years of age showed greater benefit 2.

From the Research

Pain Management in Shingles

  • Pain management is a crucial aspect of treating shingles, as the condition can cause significant discomfort and lead to complications like postherpetic neuralgia 3, 4, 5.
  • Antiviral medications such as acyclovir, valacyclovir, and famciclovir are commonly used to treat shingles, and are most effective when started within 72 hours of the onset of the rash 3, 6, 7.
  • The addition of corticosteroids to antiviral therapy may provide modest benefits in reducing pain and the incidence of postherpetic neuralgia 3, 4.
  • For patients with postherpetic neuralgia, treatment options may include:
    • Narcotics for adequate pain control 3.
    • Tricyclic antidepressants or anticonvulsants to control neuropathic pain 3, 5.
    • Topical lidocaine or capsaicin 5, 7.
    • Nerve blocks 3.
  • Combination therapy with valacyclovir, methylprednisolone, and pregabalin may be more effective than valacyclovir alone or valacyclovir with pregabalin in managing acute herpes zoster neuralgia 4.
  • The varicella zoster virus vaccine can decrease the incidence of shingles and is approved for adults 50 years and older 5.

Treatment Options

  • Acyclovir: 800 mg five times a day may be a better choice than 200 mg five times a day in treating shingles 6.
  • Valacyclovir: 900-1000 mg three times a day may be more effective than 300 mg twice a day 6.
  • Famciclovir: 250 mg three times a day may be as effective as 500 mg and 750 mg three times a day in treating shingles 6.
  • Pregabalin: may be used in combination with valacyclovir and methylprednisolone to manage acute herpes zoster neuralgia 4.

Complications

  • Postherpetic neuralgia: a common complication of shingles, characterized by pain that persists for at least 90 days after the acute infection 3, 5.
  • Ocular involvement: can lead to rare but serious complications and may require referral to an ophthalmologist 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recommendations for the management of herpes zoster.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.